Cambio Health Solutions, LLC v. Reardon

234 F. App'x 331
CourtCourt of Appeals for the Sixth Circuit
DecidedFebruary 27, 2007
Docket04-6485, 05-5041
StatusUnpublished
Cited by14 cases

This text of 234 F. App'x 331 (Cambio Health Solutions, LLC v. Reardon) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cambio Health Solutions, LLC v. Reardon, 234 F. App'x 331 (6th Cir. 2007).

Opinion

SUTTON, Circuit Judge.

Does a parent company holding a majority, but less than a 100%, interest in its subsidiary enjoy a qualified privilege to interfere with the contractual relations of that subsidiary? After determining that this question of state law remained an open one in Tennessee—and one upon which much of the $5.9 million jury verdict in this case turned—we certified the question to the Tennessee Supreme Court. Having now learned from our sister court that a company with less than a 100% interest in a subsidiary does not have a qualified privilege to interfere with the contractual relations of the subsidiary under Tennessee law, we affirm the jury’s verdict for Thomas M. Reardon on his claims against Triad Hospitals, Inc., Quorum Health Resources and the Intensive Resource Group for tortious interference with contract and procurement of a breach of contract. We thus reject this and sev *334 eral other challenges to the jury verdict, and we now affirm.

I.

On September 1,1999, Thomas M. Rear-don began working as the CEO for Cam-bio Health Solutions, LLC (Cambio), which provides consulting services to healthcare providers. Under the terms of his executive consulting agreement with Cambio, Reardon could terminate his employment with the company for “good reason” following a “change in control” at Cambio or Intensive Resource Group, LLC (IRG). IRG had an 80% interest in Cambio; Reardon obtained a 10% interest in the company as part of his compensation; and private investors held the remaining 10% interest in Cambio.

Making matters more complicated, IRG was a wholly owned subsidiary of Quorum Health Resources (QHR), which itself was wholly owned by Quorum Health Group (QHG). In April 2001, Triad Hospitals, Inc. acquired and absorbed QHG through a merger. That October, Dan Moen became an officer of Triad and CEO of QHR.

Convinced that the April 2001 merger had effectively stripped him of his responsibilities, particularly when considered in conjunction with actions taken by Moen and others after the merger, Reardon notified Cambio in a letter dated March 14, 2002, that he was terminating his employment with the company. The “change in control” stemming from the April 2001 merger, he explained, amounted to a “good reason” for leaving the company, and he thus demanded that Cambio pay him the severance benefits owed under the consulting agreement.

In response, Cambio filed this lawsuit in federal district court seeking a declaration that a change in control had not taken place. Reardon, in turn, filed a counterclaim against Cambio alleging breach of contract and named IRG, QHR and Triad as additional defendants in the lawsuit, bringing claims against the latter three companies for common law tortious interference with contract and statutory procurement of a breach of contract. See TenmCode Ann. § 47-50-109.

Reardon filed a motion for partial summary judgment, contending that as a matter of law a change in control had occurred as a result of the Triad—QHG merger. The district court granted the motion.

The parties proceeded to trial on the remaining issues. The jury found that Cambio had breached the agreement and awarded Reardon $815,000 in compensatory damages. The jury also found IRG, QHR and Triad liable on the tortious interference and procurement of a breach of contract claims, awarding $1,800,000 in punitive damages against Triad, $3,000,000 against QHR and $200,000 against IRG. Reardon, in response, filed a notice of election of remedies asking for common law punitive damages for the Triad and QHR awards but seeking statutory treble damages for the IRG award, all of which would have allowed him to recover $1,768,582.36 from IRG instead of $200,000 from this company. The district court denied Rear-don’s split-remedy request and entered judgment on the jury verdict. The companies filed renewed motions for judgment as a matter of law, new trial and remittitur, each of which the district court denied.

II.

The companies on appeal urge us to grant their motion for judgment as a matter of law on several issues and to order a new trial on several others. They also seek to eliminate the punitive damages award or at least to reduce it. Reardon, for his part, contends that he should have been permitted to split his remedies and *335 cross-appeals from the district court’s denial of that request.

A.

In reviewing the district court’s denial of a Rule 50 motion for judgment as a matter of law, we give fresh review to legal questions. K & T Enters., Inc. v. Zurich Ins. Co., 97 F.3d 171, 176 (6th Cir.1996). “Judgment as a matter of law is appropriate only when there is a complete absence of fact to support the verdict, so that no reasonable juror could have found for the nonmoving party.” Moore v. KUKA Welding Sys. & Robot Corp., 171 F.3d 1073, 1078 (6th Cir.1999). As to questions of fact regarding the sufficiency of the evidence, we look to the law of the forum state, K&T Enters., 97 F.3d at 176, which tells us (unsurprisingly) to “discard all countervailing evidence, take the strongest legitimate view of the evidence in favor of the non-moving party, and allow all reasonable inferences in his favor,” Mairose v. Fed. Express Corp., 86 S.W.3d 502, 511 (Tenn.Ct.App.2001).

IRG, QHR and Triad initially argue that, as a matter of law, they had authority to interfere with the consulting agreement between Cambio and Reardon because they held a majority interest in Cambio. In doing so, they ask us to extend the holding in Waste Conversion Sys., Inc. v. Greenstone Indus., Inc., 33 S.W.3d 779, 784 (Tenn.2000)—which provides a qualified privilege for parent companies to interfere in the contracts of their whollyoumed subsidiaries—to parent companies with mere majority interests in their subsidiaries. Thinking that the Tennessee Supreme Court was better equipped to decide this important matter of state law than we are, we certified the following question to that Court: “Does a parent company’s qualified privilege to interfere in the contractual relations of a wholly-owned subsidiary apply when the parent company has a majority interest in the subsidiary?”

The Tennessee Supreme Court, with our gratitude, recently answered the certified question. The rationale behind granting the privilege to the parent company of a wholly-owned subsidiary, the Court explained, does not apply when the parent owns less than 100% of its subsidiary. While the interests of a parent and wholly-owned subsidiary “are so closely aligned as to render them the same entity,” the same unity of interests does not necessarily exist when the parent merely owns a majority of the subsidiary’s stock. Cambio Health Solutions, LLC v. Reardon, 213 S.W.3d 785, 788 (Tenn.2006).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
234 F. App'x 331, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cambio-health-solutions-llc-v-reardon-ca6-2007.